Cogent Biosciences, Inc.COGTNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+73.0%
5Y CAGR+78.1%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+73.0%/yr
Annual compound
5Y CAGR
+78.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
17.9x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.40+483.7%
20240.07-6.8%
20230.07-4.8%
20220.08+421.6%
20210.01-33.6%
20200.02-88.3%
20190.19-
20180.00-
20170.00-
20160.00-